Vir Bio Ownership | Who Owns Vir Bio?

Overview Forecast RevenueFinancials Chart Transcripts

Vir Bio Ownership Summary

Vir Bio is owned by 65.06% institutional investors, 11.85% insiders, and 23.09% retail investors. Sb investment advisers (uk) is the largest institutional shareholder, holding 12.33% of VIR shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.23% of its assets in Vir Bio shares.

VIR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vir Bio	65.06%	11.85%	23.09%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Sb investment advisers (uk)	16.68M	12.33%	$148.49M
Blackrock	16.43M	12.15%	$146.26M
Vanguard group	12.85M	9.50%	$114.36M
State street	5.09M	3.77%	$45.34M
Baillie gifford	3.92M	2.90%	$34.90M
Orbimed advisors	2.32M	1.72%	$20.65M
Geode capital management	2.18M	1.61%	$19.44M
Morgan stanley	2.12M	1.57%	$18.90M
Bill & melinda gates foundation	1.56M	1.15%	$13.88M
Renaissance	1.33M	0.98%	$11.83M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	1.56M	23.22%	$13.88M
Sb investment advisers (uk)	16.68M	1.37%	$148.49M
Orbimed advisors	2.32M	0.41%	$20.65M
Corton capital	44.41K	0.21%	$395.28K
Sphera funds management	162.05K	0.20%	$1.44M
Adar1 capital management	110.00K	0.18%	$979.00K
Bridgeway capital management	788.70K	0.16%	$7.02M
Pdt partners	164.33K	0.14%	$1.46M
Empowered funds	493.50K	0.08%	$4.39M
Salvus wealth management	11.69K	0.07%	$104.05K

Top Buyers

Holder	Shares	% Assets	Change
Orbimed advisors	2.32M	0.41%	1.68M
Jpmorgan chase	1.26M	0.00%	792.05K
Millennium management	1.25M	0.01%	606.80K
Voloridge investment management	1.22M	0.04%	521.37K
Vanguard group	12.85M	0.00%	473.86K

Top Sellers

Holder	Shares	% Assets	Change
State street	5.09M	0.00%	-1.97M
Citigroup	84.87K	0.00%	-1.04M
Bridgeway capital management	788.70K	0.16%	-480.04K
Barclays	542.90K	0.00%	-471.78K
Rafferty asset management	145.85K	0.00%	-293.48K

New Positions

Holder	Shares	% Assets	Change	Value
Mirae asset global etfs	219.16K	0.00%	219.16K	$1.95M
Pdt partners	164.33K	0.14%	164.33K	$1.46M
Sphera funds management	162.05K	0.20%	162.05K	$1.44M
Adar1 capital management	110.00K	0.18%	110.00K	$979.00K
Trexquant investment lp	102.30K	0.01%	102.30K	$910.50K

Sold Out

Holder	Change
Northwestern mutual wealth management	-5.00
Dinuzzo private wealth	-6.00
Sjs investment consulting	-12.00
Nelson, van denburg & campbell wealth management group	-16.00
Jfs wealth advisors	-26.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	214	0.94%	88,011,508	-0.80%	65	1.50%	110	6.80%	70	9.38%
Mar 31, 2024	212	1.44%	88,721,860	0.71%	65	1.53%	103	1.98%	64	-7.25%
Dec 31, 2023	209	-2.34%	88,094,029	1.19%	65	1.56%	101	-24.63%	69	35.29%
Sep 30, 2023	214	-10.08%	87,059,491	-3.97%	64	1.41%	134	10.74%	51	-29.17%
Jun 30, 2023	238	-	90,662,885	2.29%	67	1.54%	121	2.54%	72	-4.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	5.82M	4.23%	6.11K
Scottish Mortgage Ord	3.80M	2.78%	-
Vanguard Total Stock Mkt Idx Inv	3.47M	2.52%	5.15K
Vanguard Small Cap Index	2.75M	1.99%	5.35K
iShares Russell 2000 ETF	2.31M	1.68%	-5.19K
SPDR® S&P Biotech ETF	1.92M	1.40%	21.22K
Vanguard Small Cap Growth Index Inv	1.51M	1.10%	840.00
Vanguard Institutional Extnd Mkt Idx Tr	1.43M	1.04%	23.16K
Biotech Growth Ord	1.26M	0.92%	154.30K
iShares S&P Small-Cap 600 Value ETF	939.02K	0.68%	919.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 06, 2024	de Verneuil Vanina	EVP and General Counsel	Sell	$44.45K
Nov 01, 2024	de Verneuil Vanina	EVP and General Counsel	Sell	$10.11K
Nov 05, 2024	de Verneuil Vanina	EVP and General Counsel	Sell	$22.23K
Sep 09, 2024	Napolitano Janet	-	Sell	$95.03K
Jun 11, 2024	Ramasastry Saira	-	Sell	$43.79K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	3
2024 Q3	-	1
2024 Q2	-	3
2024 Q1	-	8
2023 Q4	-	-

VIR Ownership FAQ

Who Owns Vir Bio?

Vir Bio shareholders are primarily institutional investors at 65.06%, followed by 11.85% insiders and 23.09% retail investors. The average institutional ownership in Vir Bio's industry, Biotech Stocks , is 44.97%, which Vir Bio exceeds.

Who owns the most shares of Vir Bio?

Vir Bio’s largest shareholders are Sb investment advisers (uk) (16.68M shares, 12.33%), Blackrock (16.43M shares, 12.15%), and Vanguard group (12.85M shares, 9.50%). Together, they hold 33.98% of Vir Bio’s total shares outstanding.

Does Blackrock own Vir Bio?

Yes, BlackRock owns 12.15% of Vir Bio, totaling 16.43M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 146.26M$. In the last quarter, BlackRock decreased its holdings by -129K shares, a -0.78% change.

Who is Vir Bio’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is Vir Bio’s biggest shareholder by percentage of total assets invested, with 23.22% of its assets in 1.56M Vir Bio shares, valued at 13.88M$.

Who is the top mutual fund holder of Vir Bio shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Vir Bio shares, with 4.23% of its total shares outstanding invested in 5.82M Vir Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools